SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001193125-09-175668
Filing Date
2009-08-14
Accepted
2009-08-14 13:10:12
Documents
5
Period of Report
2009-06-30
Filing Date Changed
2009-08-14

Document Format Files

Seq Description Document Type Size
1 FORM 10Q d10q.htm 10-Q 478559
2 SECTION 302 CERTIFICATION OF CEO dex311.htm EX-31.1 7120
3 SECTION 302 CERTIFICATION OF CFO dex312.htm EX-31.2 6842
4 SECTION 906 CERTIFICATION OF CEO dex321.htm EX-32.1 3454
5 SECTION 906 CERTIFICATION OF CFO dex322.htm EX-32.2 3567
  Complete submission text file 0001193125-09-175668.txt   500983
Mailing Address 2203 N. LOIS AVENUE 9TH FLOOR TAMPA FL 33607
Business Address 2203 N. LOIS AVENUE 9TH FLOOR TAMPA FL 33607 813-600-4088
Stem Cell Therapy International, Inc. (Filer) CIK: 0001360479 (see all company filings)

IRS No.: 880374180 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51931 | Film No.: 091014026
SIC: 8071 Services-Medical Laboratories
Assistant Director 9